Allergan (AGN) Was the Only Bidder for Vitae Pharmaceuticals (VTAE) - Filing

September 26, 2016 5:04 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Vitae Pharmaceuticals (NASDAQ: VTAE) 14D-9 filing shows Allergan (NYSE: AGN) was the only bidder for the company.

"J.P. Morgan gauged the interest of three of the prior potential partners that, in the view of management and J.P. Morgan, would likely have a strategic interest in Vitae and possess financial resources sufficient to consummate a potential acquisition of Vitae. J.P. Morgan explained to the Vitae Board that none of the three contacted potential counterparties submitted an offer to acquire Vitae."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Market Check

Related Entities

JPMorgan, Definitive Agreement, 14D9

Add Your Comment